This inventor holds 2 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: Siemens Healthcare Gmbh. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Stefan Prause: Innovator in CRISPR Technology
Introduction
Stefan Prause is a notable inventor based in Erlangen, Germany. He has made significant contributions to the field of genetic engineering, particularly through his work on CRISPR technology. His innovative approach has led to advancements that could impact various applications in biotechnology.
Latest Patents
Stefan Prause holds 1 patent for his invention titled "Target irrelevant guide RNA for CRISPR." This patent describes a method for obtaining an enriched population of a target polynucleotide using a synthetic single guide RNA (sgRNA) for an sgRNA-guided nucleic acid-binding protein. The invention also includes methods for obtaining a pool of target-irrelevant synthetic sgRNAs and provides a kit comprising these sgRNAs.
Career Highlights
Throughout his career, Stefan has worked with prominent companies in the healthcare sector, including Siemens Healthcare GmbH and Siemens Healthineers AG. His experience in these organizations has allowed him to collaborate on various projects that enhance medical technologies.
Collaborations
Stefan has collaborated with talented individuals such as Yiwei Huang and Maximilian Würstle. These partnerships have contributed to the development of innovative solutions in the field of genetic research.
Conclusion
Stefan Prause's work in CRISPR technology exemplifies the impact of innovative thinking in biotechnology. His contributions continue to pave the way for future advancements in genetic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile